Showing results (1-10 of 140) with videos related to
Sort By:
Pageof 14
Clinical Neuropharmacology|January 1, 1993
Serotonin selective antidepressant drugs: past, present, futureM Asberg, B MårtenssonBiological Psychiatry|December 1, 1991
Memory effects of clomipramine treatment: relationship to CSF monoamine metabolites and drug concentrations in plasmaA Bartfai, M Asberg, B Mårtensson, et al.Journal of Affective Disorders|October 1, 1990
Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorderA Wgner, D Montero, B Mårtensson, et al.The Journal of Clinical Psychiatry|April 1, 1986
Therapeutic effects of serotonin uptake inhibitors in depressionM Asberg, B Eriksson, B Mårtensson, et al.Acta Psychiatrica Scandinavica|February 1, 1991
Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorderB Mårtensson, A Wägner, O Beck, et al.Archives of General Psychiatry|October 1, 1987
Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorderA Wägner, A Aberg-Wistedt, M Asberg, et al.Psychiatry Research|October 1, 1985
Lower 3H-imipramine binding in platelets from untreated depressed patients compared to healthy controlsA Wägner, A Aberg-Wistedt, M Asberg, et al.Acta Psychiatrica Scandinavica|March 1, 1984
CSF monoamine metabolites in melancholiaM Asberg, L Bertilsson, B Mårtensson, et al.Translational Psychiatry|November 22, 2012
Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attemptersJ Isung, S Aeinehband, F Mobarrez, et al.Annals of the New York Academy of Sciences|June 9, 1998
Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studiesM AsbergPageof 14